First-line biological versus conventional synthetic disease-modifying antirheumatic drug therapy in adult-onset Still's disease: a multicentre, retrospective, propensity weighted cohort study

Kernder, Anna; Filla, Tim; Friedrich, Rhea; Blank, Norbert; Ernst, Diana; Henes, Joerg; Keysser, Gernot; Klemm, Philipp; Krusche, Martin; Meinecke, Anna; Rech, Juergen; Schulz, Nils; Petzinna, Simon Michael; Pankow, Anne; Schaefer, Valentin S.; Pfeil, Alexander; Klapa, Sebastian; Feist, Eugen; Vordenbaeumen, Stefan

dc.contributor.author	Henes, Jörg Christoph
dc.date.accessioned	2025-09-08T13:40:30Z
dc.date.available	2025-09-08T13:40:30Z
dc.date.issued	2025
dc.identifier.issn	2665-9913
dc.identifier.uri	http://hdl.handle.net/10900/170065
dc.language.iso	en	de_DE
dc.publisher	Amsterdam : Elsevier	de_DE
dc.relation.uri	http://dx.doi.org/10.1016/S2665-9913(25)00023-2	de_DE
dc.subject.ddc	610	de_DE
dc.title	First-line biological versus conventional synthetic disease-modifying antirheumatic drug therapy in adult-onset Still's disease: a multicentre, retrospective, propensity weighted cohort study	de_DE
dc.type	Article	de_DE
utue.quellen.id	20250630000000_00321
utue.publikation.seiten	e415-e423	de_DE
utue.personen.roh	Kernder, Anna
utue.personen.roh	Filla, Tim
utue.personen.roh	Friedrich, Rhea
utue.personen.roh	Blank, Norbert
utue.personen.roh	Ernst, Diana
utue.personen.roh	Henes, Joerg
utue.personen.roh	Keysser, Gernot
utue.personen.roh	Klemm, Philipp
utue.personen.roh	Krusche, Martin
utue.personen.roh	Meinecke, Anna
utue.personen.roh	Rech, Juergen
utue.personen.roh	Schulz, Nils
utue.personen.roh	Petzinna, Simon Michael
utue.personen.roh	Pankow, Anne
utue.personen.roh	Schaefer, Valentin S.
utue.personen.roh	Pfeil, Alexander
utue.personen.roh	Klapa, Sebastian
utue.personen.roh	Feist, Eugen
utue.personen.roh	Vordenbaeumen, Stefan
dcterms.isPartOf.ZSTitelID	Lancet Rheumatology	de_DE
dcterms.isPartOf.ZS-Issue	6	de_DE
dcterms.isPartOf.ZS-Volume	7	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE